• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,977.32 -32.38
( -0.04%)
Global Indices
Nasdaq
50,493.86 -106.84
(-0.21%)
Dow Jones
7,540.47 46.00
(0.61%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,499.42 33.16
(0.32%)
Forex
USD-INR
95.26 -0.35
(-0.37%)
EUR-INR
110.89 -0.08
(-0.07%)
GBP-INR
128.53 0.11
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524558
INE794A01010
1453.5908993
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEULANDLAB
60.27
21883.81
EPS(TTM)
Face Value()
Div & Yield %
283.01
10
0.2
 

cinevista ltd
D-Link India standalone net profit rises 0.48% in the March 2026 quarter
May 09,2026
Net profit of D-Link India rose 0.48% to Rs 27.27 crore in the quarter ended March 2026 as against Rs 27.14 crore during the previous quarter ended March 2025. Sales rose 20.10% to Rs 442.12 crore in the quarter ended March 2026 as against Rs 368.13 crore during the previous quarter ended March 2025.

For the full year,net profit declined 0.10% to Rs 102.95 crore in the year ended March 2026 as against Rs 103.05 crore during the previous year ended March 2025. Sales rose 13.21% to Rs 1559.02 crore in the year ended March 2026 as against Rs 1377.16 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales442.12368.13 20 1559.021377.16 13
OPM %7.878.76 -8.419.17 -
PBDT38.1238.23 0 145.16144.58 0
PBT36.4136.62 -1 138.53138.03 0
NP27.2727.14 0 102.95103.05 0